ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii

R Paton1, R S Miles, J Hood

  • 1Department of Medical Microbiology, University of Edinburgh Medical School, Edinburgh, UK.

Insights

Acinetobacter baumannii strain 6B92 exhibited resistance to multiple antibiotics, including imipenem. Researchers identified a novel beta-lactamase, ARI 1, responsible for this resistance, which was lost when the bacteria were treated with ethidium bromide.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Acinetobacter baumannii is an opportunistic pathogen frequently associated with hospital-acquired infections.
  • Antibiotic resistance in A. baumannii, particularly to carbapenems like imipenem, poses a significant clinical challenge.
  • Beta-lactamases are enzymes that confer resistance to beta-lactam antibiotics by hydrolyzing their core structure.

Purpose of the Study:

  • To characterize the beta-lactamase enzymes responsible for imipenem and broad-spectrum cephalosporin resistance in a clinical isolate of Acinetobacter baumannii.
  • To investigate the genetic basis of this antibiotic resistance, including the potential role of plasmids.

Main Methods:

  • Isolation and characterization of a resistant Acinetobacter baumannii strain (6B92).
  • Protein extraction, isoelectric focusing, and enzyme assays to identify and characterize beta-lactamases.
  • Treatment with ethidium bromide to assess the stability of resistance and the role of plasmids.
  • Determination of enzyme molecular size and inhibition profiles.

Main Results:

  • The resistant strain possessed two beta-lactamases: a high pI chromosomal cephalosporinase and a novel beta-lactamase, ARI 1 (pI 6.65).
  • Treatment with ethidium bromide cured the imipenem and penicillin resistance, coinciding with the loss of ARI 1, but no resistance plasmid was detected.
  • ARI 1 slowly hydrolyzed penicillin, ampicillin, and cephaloridine, and inactivated imipenem via a mechanism demonstrable only microbiologically.
  • ARI 1 has a molecular size of 23 kDa and is not inhibited by common inhibitors like EDTA, p-CMB, or clavulanate.

Conclusions:

  • A novel beta-lactamase, ARI 1, contributes significantly to imipenem resistance in Acinetobacter baumannii.
  • The resistance mechanism associated with ARI 1 may be chromosomally encoded or involve a non-visualized/non-transferable plasmid.
  • Further investigation is needed to elucidate the precise genetic basis and mechanism of imipenem inactivation by ARI 1.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...